Lilly Korea Plans to Launch Zyprexa IntraMuscular

Published: 2005-03-14 06:57:00

Updated: 2005-03-14 06:57:00

Lilly Korea recently announced that it plans to introduce Zyprexa IntraMuscular (olanzapine for injection) in the domestic market during the first half of this year, giving the healthcare professionals a new option for the rapid control of acute agitation and disturbed behaviors in patients with schizophrenia and bipolar mania.

According to the company, Zyprexa IntraMuscular (IM) is the firs...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.